Chemokine blockade for lupus model mice.

Chemokine blockade for lupus model mice. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Chemokine blockade for lupus model mice. Abstract Text:

Hitoshi Hasegawa,Hitoshi Hasegawa,

Over the past decade, accumulating evidence has indicated a crucial role for chemokines and chemokine receptors in the pathogenesis of autoimmune diseases in both human and mouse models. Locally secreted chemokines and their receptors are important mediators of leukocyte recruitment to the tissues, and contribute to the initiation and progression of autoimmune diseases. Thus, blockade of chemokine and chemokine receptor interactions has emerged as a novel therapeutic strategy. MRL/MpJ-lpr/lpr (MRL/lpr) and (NZB X NZW) F1 mice, the two strains of mice that develop spontaneous autoimmune disease closely resembling human systemic lupus erythematosus (SLE), are considered to be excellent models for investigating the pathogenesis of the human disease. In addition, similar expression patterns of chemokines and chemokine receptors in inflamed organs are shown in humans and lupus model mice, especially MRL/lpr mice. Therefore, findings obtained from experiments with lupus model mice may be applicable to the treatment of these autoimmune diseases in humans. In this article, we review the role of chemokines and chemokine receptors involved in the pathogenesis of autoimmune diseases and the therapeutic approach of chemokine blockade in lupus model mice.

Chemokine blockade for lupus model mice. Publishing Authors By Initials

H Hasegawa,H Hasegawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Chemokine blockade for lupus model mice. Journal Published:

PUBLICATION TYPE: Review

Journal: Frontiers in bioscience : a journal and virtual li

VOLUME: 13

Page Numbers: 2900-8

Journal Abbreviation: Front. Biosci.

ISSN: 1093-4715

DAY: 1

MONTH: 01

YEAR: 2008

Chemokine blockade for lupus model mice. Information

Number of References: 73

LANGUAGE: eng

NlmUniqueID: 9709506

Chemokine blockade for lupus model mice. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Chemokine blockade for lupus model mice. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Chemokine blockade for lupus model mice.

AFFILIATION: Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa 454, Toon city, Ehime 791-0295, Japan. hitoshih@m.ehime-u.ac.jp

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Front Biosci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Chemokine blockade for lupus model mice Related Publications

• An enhanced self-organizing incremental neural network for online unsupervised learning.
• Body mass index reference values (mean and SD) for Japanese children.
• Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies.
• Central administration of neuromedin U suppresses food intake in chicks.
• Chemokine blockade for lupus model mice.
• Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
• Distribution of inclusion bodies in tissues from 100 dogs infected with canine distemper virus.
• Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells.
• Effect of prostaglandin E2 on recombinant human bone morphogenetic protein-2-stimulated osteoblastic differentiation in human periodontal ligament cells.
• Extraskeletal osteosarcoma of the jaw.
• Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.
• Interferon-gamma inhibits collagen phagocytosis in human fibroblasts by inducing subcortical actin assembly and reducing ability of beta1 integrin to bind to collagen.
• Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.
• Parkinson's Disease Treatment Guidelines 2002 issued by Societas Neurologica Japonica.
• Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells.
• Phylogenetic relationships of rodent pinworms (genus Syphacia) in Japan inferred from mitochondrial CO1 gene sequences.
• Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
• Production of inhibin A and inhibin B in boars: changes in testicular and circulating levels of dimeric inhibins and characterization of inhibin forms during testis growth.
• Progress in SPECT/CT imaging of prostate cancer.
• Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
• Recombinant human bone morphogenetic protein-2 stimulates osteoblast differentiation and suppresses matrix metalloproteinase-1 production in human bone cells isolated from mandibulae.
• Recombinant human bone morphogenetic protein-2 stimulates osteoblastic differentiation in cells isolated from human periodontal ligament.
• Role of neutrophils in acute inflammatory liver injury.
• Sensor fusion for taste sensor and odor sensor.
• Single nucleotide polymorphism genotyping of CYP2C19 using a new automated system.
• Sumoylation, a post-translational regulatory process in plants.
• [Detection of FDG-PET and FDG-PET/CT in head and neck squamous cell carcinoma]
• [Homocysteine metabolism]
• [Non-Q wave myocardial infarction (N-QMI)]
• [Subendocardial infarction]